Brief: PolyPeptide Group H1 Revenue EUR 135.043 Million
13/08/2024 06:02
Aug 13 (Reuters) - PolyPeptide Group H1 cash flow from operating activities EUR 471 thousand. * H1 net income EUR -11.386 million * H1 capex EUR 20.537 million * H1 EBIT EUR -12.571 million * H1 EBITDA EUR 2.869 million
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)